Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial

Schmoll, Hans-Joachim; Lindner, Lars H.; Reichardt, Peter; Heissner, Klaus; Kopp, Hans-Georg; Kessler, Torsten; Mayer-Steinacker, Regine; Ruessel, Joern; Egerer, Gerlinde; Crysandt, Martina; Kasper, Bernd; Niederwieser, Dietger; Kunitz, Annegret; Eigendorff, Ekkehard; Petersen, Iver; Steighardt, Joerg; Cygon, Franziska; Meinert, Fabian; Stein, Alexander

Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial

Autor(en):

Schmoll, Hans-Joachim; Lindner, Lars H.; Reichardt, Peter; Heissner, Klaus; Kopp, Hans-Georg; Kessler, Torsten; Mayer-Steinacker, Regine; Ruessel, Joern; Egerer, Gerlinde; Crysandt, Martina; Kasper, Bernd; Niederwieser, Dietger; Kunitz, Annegret; Eigendorff, Ekkehard; Petersen, Iver; Steighardt, Joerg; Cygon, Franziska; Meinert, Fabian; Stein, Alexander

Tübinger Autor(en):

Kopp, Hans-Georg

Erschienen in:

Jama Oncology (2021), Bd. 7, H. 2, S. 255-262

Verlagsangabe:

Amer Medical Assoc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1001/jamaoncol.2020.6564

ISSN:

2374-2445